Translational research institution (a.k.a. De Haar Research Foundation or Task Force) with research focuses on the bench-to-bedside studies in interventional cardiovascular biomedicine, biomedical engineering, and nanomedicine. The Company provides (1) an outsourcing support of the bench studies, (2) a full service of the Cardiovascular Contract Research Organization with the outsourcing involvement of the experts in the field of the interest, (3) a professional Core Laboratory with a strong expertise and a leading validated internationally-recognized software in QCA (quantitative coronary angiography), IVUS (intravascular ultrasound), OCT (optical coherence tomography), and CT (computed tomography) including a broad social and academic networking. The main objective of the company is to drive the international research collaboration developing and promoting innovations with the final target to conquer atherosclerosis, vascular, myocardial, and structural disorders, and therefore dramatically reduce cardiovascular mortality across the globe.
The structure of DHRF includes a few labs including divisions in Rotterdam, Amsterdam (The Netherlands) and Tallinn (Estonia).
Company Details
- Founded
- -
- Address
- Keurenplein 41, Box G9950, Amsterdam,north Holland 1069cd,netherlands
- Industry
- Research
- Website
- dhrf.com
- HQ
- Amsterdam, North Holland
De Haar Research Task Force | Foundation (Dhrf) Questions
De Haar Research Task Force | Foundation (Dhrf)'s website is dhrf.com
De Haar Research Task Force | Foundation (Dhrf)'s LinkedIn profile is https://nl.linkedin.com/company/de-haar-research-foundation
De Haar Research Task Force | Foundation (Dhrf)'s industry is
Research
De Haar Research Task Force | Foundation (Dhrf)'s top competitors are
Annogen,
Biomedical Engineering For Global Health,
Insteps Bv,
Multi-Modality Medical Imaging (M3i),
Aiosyn,
Esaote.
De Haar Research Task Force | Foundation (Dhrf)'s categories are Research
De Haar Research Task Force | Foundation (Dhrf)'s founding year is 2013
